Skip to content

Author

Huafeng Wang

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

CD84 expression stratifies venetoclax response and reveals a targetable vulnerability in resistant acute myeloid leukemia

Venetoclax-based regimens have become increasingly integrated into the therapeutic landscape of acute myeloid leukemia (AML), yet primary resistance and relapses remain major barriers to durable benefits. Building on our previous discovery of CD84 as a critical survivor and redox regulator in AML, we here demonstrate t...

Xue-Mei Wang, Xiang-Jie Lin, Tian-Yi Chen et al. · 0 citations
Aug 2026

Oncogenic DHX15 mutation enhances mitochondrial metabolism and sustains leukemia stemness.

Functional analysis demonstrates that DHX15R222G cooperates with AML1-ETO fusion protein to enhance AML leukemia stem cell (LSC) activity and promote resistance to standard chemotherapy, and underscores the pivotal role of oncogenic DHX15 mutations in regulating AML LSC activity.

Qi-Long Li, Pei-Qi Xing, Jin Xu et al. · 0 citations
Case report Open access Aug 2026

Identification of novel UBE2E3::PDE1A and CTC1::MEF2C fusion transcripts in acute myeloid leukemia

Using mRNA sequencing, two novel fusion genes are identified and validated and it is proposed that the combination of these novel fusion genes, multiple SNVs, and the complex karyotype collectively contributed to the patient’s multidrug resistance.

Jifang Tu, Yungui Wang, Xiangli Gao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.